by Paul Pyzowski
Contributing Editor, MEMS Investor Journal
As an executive and entrepreneur who transitioned from the semiconductor industry to life sciences, I am often asked about "medical MEMS" by other executives, engineers, and investors seeking new markets for an existing MEMS or microfabrication technology. These questions include how to identify a need, how to think about partnering and commercialization, and even whether to get into medical markets at all.
First, in spite of uncertainties due to healthcare reform efforts in the US, I am optimistic about the increasing use of MEMS in health and medicine. The life sciences and health markets in mature Western economies are both enormous, comprising 17% of the US economy, as well as incredibly diverse including cancer drugs, hospital equipment, and home healthcare technology.
Continue reading "Health and medical market strategies for MEMS companies" »